POLISCOPE
Back to feed
HB 353FLORIDA · STATEWIDESession 2026Laid on Table, refer to CS/SB 844

New Continuing Education Requirements for Prescribers

Original title: Sickle Cell Disease Treatment of Pain Continuing Education

November 5, 2025

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Where This Stands

Currently Laid on Table, refer to CS/SB 844. The next step in the legislative lifecycle is Introduced.

Procedural history

18 actions
  1. Feb 25, 2026House
    Added to Second Reading Calendar
  2. Feb 25, 2026House
    Bill released to House Calendar
  3. Feb 25, 2026House
    Reported out of Health & Human Services Committee
  4. Feb 24, 2026HouseCommittee
    Favorable by Health & Human Services Committee
  5. Feb 20, 2026House
    Added to Health & Human Services Committee agenda
  6. Feb 12, 2026House
    Now in Health & Human Services Committee
Show 12 earlier actions
  1. Feb 12, 2026HouseCommittee
    Referred to Health & Human Services Committee
  2. Feb 11, 2026HouseIntroduced
    1st Reading (Committee Substitute 1)
  3. Feb 11, 2026HouseIntroduced
    CS Filed
  4. Feb 11, 2026House
    Laid on Table under Rule 7.18(a)
  5. Feb 11, 2026House
    Reported out of Health Professions & Programs Subcommittee
  6. Feb 11, 2026HouseCommittee
    Favorable with CS by Health Professions & Programs Subcommittee
  7. Feb 9, 2026House
    PCS added to Health Professions & Programs Subcommittee agenda
  8. Jan 13, 2026HouseIntroduced
    1st Reading (Original Filed Version)
  9. Nov 12, 2025House
    Now in Health Professions & Programs Subcommittee
  10. Nov 12, 2025HouseCommittee
    Referred to Health & Human Services Committee
  11. Nov 12, 2025HouseCommittee
    Referred to Health Professions & Programs Subcommittee
  12. Nov 5, 2025HouseIntroduced
    Filed

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

The Frame

What this does

This change mandates that all Florida-licensed prescribers of update their clinical knowledge regarding sickle cell pain management as a condition for maintaining their legal authority to practice.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Medical prescribers

Must complete specific continuing education on sickle cell disease to maintain their license to prescribe controlled substances.

Patients with sickle cell disease

The bill mandates that their specific pain management needs be included in the required training for their healthcare providers.

What changed

Last recorded activity November 5, 2025.

What's next

Introduced.

Summary

This bill requires doctors and other medical professionals who prescribe to complete a specific continuing education course on treating pain in patients with sickle cell disease. Professionals who do not complete this training will be unable to renew their medical licenses.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

Who is required to take this course?
Any person registered with the U.S. Drug Enforcement Administration who is authorized to prescribe in Florida.
What happens if I don't take the course?
The department will not renew your professional license.
Can I take this course online?
Yes, the bill explicitly allows the course to be offered in a distance learning format.

Why It Matters

This change mandates that all Florida-licensed prescribers of update their clinical knowledge regarding sickle cell pain management as a condition for maintaining their legal authority to practice.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Voting Record

Sponsors

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Integration of Specialized Pain Management into General Education

The bill shifts from general controlled substance education to requiring specific clinical focus on sickle cell disease, indicating a policy effort to address health disparities in pain management.

Connected Entities

organizationHealth & Human Services CommitteeCommittee reviewing the billMap →
otherRule 7.18(a)Procedural rule regarding bill dispositionMap →
organizationHealth Professions & Programs SubcommitteeSubcommittee reviewing the billMap →
locationHouse CalendarWhere the bill is scheduled for considerationMap →

Sources

Open source document

openstates.org

Analysis Score

0–100
  • Significance60
    How much this matters to a regular citizen
  • Controversy10
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz20
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record